S5 Ep5: Boards and sponsors must look beyond retention to ensure leadership capabilities and compensation strategies support a successful transition and long-term value creation.

As business priorities shift, compensation committees must ensure incentive plans continue to reward the right executive behaviors and outcomes.

A broad assessment of leadership and strategic results can help boards determine whether pay outcomes appropriately reflect overall performance.

S5 Ep4: Market volatility and the challenge of setting long-term performance goals are prompting companies to rethink the traditional incentive mix—and reconsider the role of stock options.

Life sciences companies can introduce performance stock units (PSUs) without unnecessary complexity by using achievable, time-bound milestones that align executive rewards with meaningful business outcomes.

S5 Ep3: How companies can maintain strong governance and investor trust as the disclosure landscape evolves.

Boards can better assess transaction incentives by considering existing equity, shareholder impact, and how payouts change as deal value increases.

S5 Ep2: How boards can move beyond succession planning to succession readiness by defining what the future CEO role requires and deliberately developing and testing potential successors to ensure they’re prepared to lead.

Shifting expectations around compensation, leadership, governance, and business strategy are challenging established practices and giving compensation committees reason to reassess their approach for the year ahead.

S5 Ep1: How committees can align incentive designs with transformation priorities like AI, M&A, portfolio shifts, and new market growth while maintaining financial discipline and avoiding unnecessary complexity.